Narayana Hrudaya
Narayana Hrudaya Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
Guidance rank: #26 of 32 in Healthcare Services
See the sector's top 10 — free with your mobile number.
What the Q1 FY27 call signalled
3 of 4 strong
The short version
India hospital business shows strong revenue growth driven by a combination of increased footfalls and ARPOB (Average Revenue Per Occupied Bed). Debt levels expected to rise for the next 2-3 years due to project construction but anticipated to reduce by FY30, improving financials.
From Narayana Hrudaya's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- India hospital business shows strong revenue growth driven by a combination of increased footfalls and ARPOB (Average Revenue Per Occupied Bed).
- Clinics contribute significantly, with OP consults growing about 30% YoY and 66,000 consultations in Q1, supporting hospital footfalls and overall revenue.
- Expansion plans include adding new beds, such as the Southwest Bangalore project expected to start by end of Q2 FY27.
- Focused capital deployment in clusters where the company already has presence, with possible new geographic markets considered after Phase 1 progress.
- Efforts to change payer mix in the UK from mainly NHS to a more balanced one with private and self-pay revenues, expected to increase private contribution over time.
2 more points from Narayana Hrudaya's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Narayana Hrudaya said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company has an outlined capital deployment plan focused on expansion within clusters where they already have a strong presence, over the next 3 financial years.
- Projects include hospital expansions such as the North Bangalore project, prioritized in their second round of expansion.
- Some projects have been postponed slightly due to partner-related licensing delays but remain within acceptable timeframes.
- The Southwest Bangalore 100-bed project is expected to start by end of Q2 FY27.
- Capital investment will continue with a focus on affordable care philosophy, balancing leverage benefits, new growth verticals like integrated care, and customer returns.
- The UK business acquisition involves no significant further capital deployment currently; focus is on improving earnings from existing capital.
2 more points from Narayana Hrudaya's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Narayana Hrudaya said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Narayana Hrudaya said on order book & pipeline — free account, 30 seconds.
Narayana Hrudaya — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.8K Cr, net profit ₹301 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Narayana Hrudayalaya Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Aatmaj Health (Q1 FY27)
Revenue for Q1 FY 2026-27: ₹8.13 crore . Key investor presentation takeaways from Aatmaj Healthcare Ltd's Q1 FY27 investor presentation — and how it ranks again
- Asarfi Hospital Ltd (Q1 FY27)
Q1'FY27 consolidated revenue from operations: ₹47.5 Cr, up 32.8% YoY (vs ₹35.7 Cr in Q1'FY26) . Key investor presentation takeaways from Asarfi Hospital Ltd's Q
- KMC Speciality (Q1 FY27)
Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26. Key concall takeaways from KMC Speciality Hospitals (India) Ltd's Q1…
- 3B Blackbio (Q1 FY27)
Q1 2026-27 revenue from operations: ₹3,205.73 Lakh (including Coris sales of ₹862.83 Lakh) vs ₹1,996.06 Lakh in Q1 2025-26 — YoY growth approx. Key concall…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Narayana Hrudaya and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Narayana Hrudaya Q1 FY27 results?
India hospital business shows strong revenue growth driven by a combination of increased footfalls and ARPOB (Average Revenue Per Occupied Bed). Debt levels expected to rise for the next 2-3 years due to project construction but anticipated to reduce by FY30, improving financials.
What is Narayana Hrudaya share price analysis?
Narayana Hrudaya currently shows a below-average growth signal. The stock trades at a P/E of 43.0 with a market cap of ₹37,108 Cr. Investors should review the full earnings analysis for detailed insights.
Is Narayana Hrudaya planning capital expenditure?
The company has an outlined capital deployment plan focused on expansion within clusters where they already have a strong presence, over the next 3 financial years.
Keep Narayana Hrudaya on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.